FDA Clears Single-Use Antibacterial Surgical Respirator
The U.S. Food and Drug Administration cleared the SpectraShield 9500 N95 surgical respirator, a device that kills 99.99 percent of three different kinds of bacteria when exposed to its outer surface.
The FDA has cleared the SpectraShield as a single-use, N95 surgical respirator for use in healthcare settings by healthcare personnel to protect against microorganisms, body fluids and particulate material.
Data from laboratory tests demonstrated that the respirator is effective against the following bacteria: Streptococcus pyogenes, methicillin-resistant Staphylococcus aureus (MRSA) and Haemophilus influenzae.
"The SpectraShield 9500 N95 anti-bacterial surgical respirator may reduce the risk of exposure to specific bacterial agents during medical emergencies," says Elizabeth Claverie-Williams, branch chief of Infection Control Devices at the FDA's Center for Devices and Radiological Health.
N95 surgical respirators are different than regular facemasks, which are designed to help block large-particle droplets, splashes, sprays, or splatter that may contain viruses and bacteria from reaching the mouth and nose.
While a regular facemask may be effective in blocking splashes and large-particle droplets, it does not filter or block tiny particles that may be transmitted by coughs, sneezes, or certain medical procedures. Regular facemasks also do not provide complete protection from germs and other contaminants because of the loose fit between the surface and the face.
The N95 designation means that the respirator blocks at least 95 percent of very small particles when subjected to careful testing. If properly fitted, the capabilities of N95 respirators exceed those of regular facemasks. Even a properly fitted N95 respirator, however, does not eliminate the risk of infection, illness, or death.
N95 surgical respirators cleared by the FDA for use in healthcare settings, including the SpectraShield 9500 N95 surgical respirator, have also been evaluated by the National Institute for Occupational Safety and Health, part of the Centers for Disease Control and Prevention.
Getting Down and Dirty With PPE: Presentations at HSPA by Jill Holdsworth and Katie Belski
June 26th 2025In the heart of the hospital, decontamination technicians tackle one of health care’s dirtiest—and most vital—jobs. At HSPA 2025, 6 packed workshops led by experts Jill Holdsworth and Katie Belski spotlighted the crucial, often-overlooked art of PPE removal. The message was clear: proper doffing saves lives, starting with your own.
Spring Into Safety: How Seasonal Deep Cleaning Strengthens Hospital Infection Control
June 13th 2025Rooted in ancient rituals of renewal, spring-cleaning has evolved from cultural tradition to a vital infection prevention strategy in modern hospitals—one that blends seasonal deep cleaning with advanced disinfection to reduce pathogens, improve air quality, and protect patients.
